Cardamonin and DMF, having anti-inflammatory and antioxidant effects, improved colitis in a DSS-induced colitis mouse model through activation of the Nrf2 pathway, thus reducing the activation of caspase-1 and the release of effector molecules [149,150]. This evidence concerns the gene CASP1 and colitis.